cetazime 2 g por injekcióhoz
t3a pharma group gmbh - ceftazidime -
fucidin por infúzióhoz
leo pharma a/s - fuzidinsav -
cetazime 0,5 g por injekcióhoz
t3a pharma group gmbh - ceftazidime -
cetazime 1 g por injekcióhoz
t3a pharma group gmbh - ceftazidime -
amoksiklav 500/125 mg por ivóvízbe keveréshez sertések részére a.u.v.
elanco gmbh - kálium-klavulanát, amoxicillin-trihidrát - por ivóvízbe keveréshez - amoxicillin and enzyme inhibitor - sertés
pathozone 25 mg/ml intramammális szuszpenzió szarvasmarhák részére a.u.v.
zoetis hungary kft. - cefoperazon-nátrium - intramammális oldat - cefoperazone - szarvasmarha
3fluart szuszpenziós injekció
fluart innovative vaccines kft - vakcina (virális) -
sivextro
merck sharp & dohme b.v. - tedizolid foszfátot - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - daganatellenes szerek - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
salmoporc vakcina a.u.v. liofilizátum belsoleges szuszpenzióhoz
ceva-phylaxia oltóanyagtermelo zrt. - salmonella typhimurium - liofilizátum szuszpenziós injekcióhoz - salmonella vaccine - sertés